A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
NCT07753226
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Solid Tumor
Interventions
DRUG:
SI-B036
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators
[object Object]